WO2000050047A3 - Composicion para el tratamiento de la psoriasis - Google Patents

Composicion para el tratamiento de la psoriasis Download PDF

Info

Publication number
WO2000050047A3
WO2000050047A3 PCT/CU2000/000001 CU0000001W WO0050047A3 WO 2000050047 A3 WO2000050047 A3 WO 2000050047A3 CU 0000001 W CU0000001 W CU 0000001W WO 0050047 A3 WO0050047 A3 WO 0050047A3
Authority
WO
WIPO (PCT)
Prior art keywords
psoriasis
treatment
formulation
composition
epidermis
Prior art date
Application number
PCT/CU2000/000001
Other languages
English (en)
French (fr)
Other versions
WO2000050047A2 (es
Inventor
Cao Carlos Manuel Miyares
Original Assignee
Ct De Histoterapia Placentaria
Cao Carlos Manuel Miyares
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct De Histoterapia Placentaria, Cao Carlos Manuel Miyares filed Critical Ct De Histoterapia Placentaria
Priority to CA002363036A priority Critical patent/CA2363036A1/en
Priority to UA2001096494A priority patent/UA71605C2/uk
Priority to JP2000600658A priority patent/JP2002537342A/ja
Priority to BR0008394-1A priority patent/BR0008394A/pt
Priority to AT00907415T priority patent/ATE226440T1/de
Priority to EP00907415A priority patent/EP1159966B1/en
Priority to DE60000658T priority patent/DE60000658T2/de
Publication of WO2000050047A2 publication Critical patent/WO2000050047A2/es
Publication of WO2000050047A3 publication Critical patent/WO2000050047A3/es
Priority to BG105924A priority patent/BG105924A/xx
Priority to HK02104260A priority patent/HK1043938A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composición para el tratamiento de la psoriasis, con actividad reguladora de la velocidad de regeneración cutánea. Contiene como principio activo un extracto alcohólico derivado de placenta humana y un excipiente hidrosoluble en forma de gel. Dicho extracto alcohólico está constituido fundamentalmente por ácidos grasos insaturados, tales como el palmitoleico y el oleico, y por ácidos grasos poli-insaturados, tales como el linoleico, araquidónico y eicosatrienoico.
PCT/CU2000/000001 1999-02-22 2000-02-22 Composicion para el tratamiento de la psoriasis WO2000050047A2 (es)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CA002363036A CA2363036A1 (en) 1999-02-22 2000-02-22 Composition for the treatment of psoriasis
UA2001096494A UA71605C2 (en) 1999-02-22 2000-02-22 Composition for treatment of psoriasis based on ethanol extract from human placenta
JP2000600658A JP2002537342A (ja) 1999-02-22 2000-02-22 乾せんの治療のための組成物
BR0008394-1A BR0008394A (pt) 1999-02-22 2000-02-22 Composição para o tratamento da psorìase
AT00907415T ATE226440T1 (de) 1999-02-22 2000-02-22 Zusammensetzung zur behandlung von psoriasis
EP00907415A EP1159966B1 (en) 1999-02-22 2000-02-22 Composition for the treatment of psoriasis
DE60000658T DE60000658T2 (de) 1999-02-22 2000-02-22 Zusammensetzung zur behandlung von psoriasis
BG105924A BG105924A (en) 1999-02-22 2001-09-20 Composition for the treatment of psoriasis
HK02104260A HK1043938A1 (en) 1999-02-22 2002-06-05 Composition for the treatment of psoriasis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU16/99 1999-02-22
CU1999016A CU22693A1 (es) 1999-02-22 1999-02-22 Composición para el tratamiento de la psoriasis y método para su obtención

Publications (2)

Publication Number Publication Date
WO2000050047A2 WO2000050047A2 (es) 2000-08-31
WO2000050047A3 true WO2000050047A3 (es) 2000-12-21

Family

ID=5459199

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CU2000/000001 WO2000050047A2 (es) 1999-02-22 2000-02-22 Composicion para el tratamiento de la psoriasis

Country Status (16)

Country Link
EP (1) EP1159966B1 (es)
JP (1) JP2002537342A (es)
CN (1) CN1165299C (es)
AR (1) AR022704A1 (es)
AT (1) ATE226440T1 (es)
BG (1) BG105924A (es)
BR (1) BR0008394A (es)
CA (1) CA2363036A1 (es)
CU (1) CU22693A1 (es)
DE (1) DE60000658T2 (es)
ES (1) ES2187446T3 (es)
HK (1) HK1043938A1 (es)
HU (1) HUP0200005A3 (es)
RU (1) RU2225717C2 (es)
UA (1) UA71605C2 (es)
WO (1) WO2000050047A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20040423A1 (it) * 2004-03-04 2004-06-04 Pier Mario Biava Uso di un estratto di embrioni di ovipari e di mucosa di utero gravido o di placenta di mammiferi non umani per la preparazione di un prodotto di attivita' antipsoriasica
CN102688483B (zh) * 2011-03-22 2015-02-18 王成德 一种治疗皮肤病的组合物、含有该组合物的制剂及其制备方法
RU2599038C1 (ru) * 2015-10-22 2016-10-10 Общество с ограниченной ответственностью Медицинская Корпорация "РАНА" Применение препарата лаеннек для лечения заболевания, связанного с нарушением иммунитета, представляющего собой хронический рецидивирующий герпес, атопический дерматит или псориаз
CN112168812B (zh) * 2019-07-02 2022-07-08 瑞微（深圳）生物科技有限公司 棕榈油酸用于制备预防或治疗炎症性疾病的组合物的用途
CN114544783B (zh) * 2020-11-20 2024-01-30 上海交通大学医学院附属瑞金医院 一种预防银屑病复发的内源性代谢物组合

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1061818A1 (ru) * 1982-07-19 1983-12-23 Центральный научно-исследовательский кожно-венерологический институт Способ лечени пустулезного псориаза
CN1098310A (zh) * 1994-02-02 1995-02-08 李庆和 治疗牛皮癣的中药克癣丸
WO1995034310A1 (en) * 1994-06-10 1995-12-21 Aktsionernoe Obschestvo Zakryt Medicament base
WO1997048405A1 (fr) * 1996-06-21 1997-12-24 Jury Evgenievich Belyaev Produit semi-fini permettant d'obtenir des bases de medicaments, bases de medicaments obtenues a l'aide ce dernier et variantes, et medicament faisant appel a ces bases et variantes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1061818A1 (ru) * 1982-07-19 1983-12-23 Центральный научно-исследовательский кожно-венерологический институт Способ лечени пустулезного псориаза
CN1098310A (zh) * 1994-02-02 1995-02-08 李庆和 治疗牛皮癣的中药克癣丸
WO1995034310A1 (en) * 1994-06-10 1995-12-21 Aktsionernoe Obschestvo Zakryt Medicament base
WO1997048405A1 (fr) * 1996-06-21 1997-12-24 Jury Evgenievich Belyaev Produit semi-fini permettant d'obtenir des bases de medicaments, bases de medicaments obtenues a l'aide ce dernier et variantes, et medicament faisant appel a ces bases et variantes

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EPODOC EUROPEAN PATENT OFFICE, THE HAGUE, NL; XP002901074 *
DATABASE STN INTERNATION. [online] NOVIKOVA Z I: "Effect of placenta suspension on the immunologic indicators and dynamics of skin changes in patients with palmar and plantar pustulous psoriasis", XP002901078, retrieved from MEDLINE accession no. 86099200 *
DATABASE WPI Section Ch Week 198433, Derwent World Patents Index; Class B04, AN 1984-206318, XP002901076 *
DATABASE WPI Section Ch Week 199605, Derwent World Patents Index; Class B04, AN 1996-049410, XP002901075 *
DATABASE WPI Section Ch Week 199721, Derwent World Patents Index; Class B04, AN 1997-227094, XP002901077 *
VESTNIK DERMATOLOGII I VENEROLOGII, no. 10, October 1985 (1985-10-01), pages 46 - 48, ISSN: X9U-0042-4609 *

Also Published As

Publication number Publication date
BR0008394A (pt) 2002-11-19
CN1165299C (zh) 2004-09-08
HK1043938A1 (en) 2002-10-04
DE60000658D1 (de) 2002-11-28
EP1159966B1 (en) 2002-10-23
ES2187446T3 (es) 2003-06-16
CU22693A1 (es) 2001-07-31
HUP0200005A2 (hu) 2002-05-29
CA2363036A1 (en) 2000-08-31
CN1347324A (zh) 2002-05-01
BG105924A (en) 2002-04-30
JP2002537342A (ja) 2002-11-05
RU2225717C2 (ru) 2004-03-20
DE60000658T2 (de) 2003-06-26
ATE226440T1 (de) 2002-11-15
HUP0200005A3 (en) 2003-03-28
EP1159966A2 (en) 2001-12-05
AR022704A1 (es) 2002-09-04
UA71605C2 (en) 2004-12-15
WO2000050047A2 (es) 2000-08-31

Similar Documents

Publication Publication Date Title
EA200600076A1 (ru) Композиции и способы увеличения активности теломеразы
WO1998010767A3 (en) Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
BR0015604A (pt) Método para o tratamento de cicatrizes hipertróficas de modo a reduzir o tamanho e/ou melhorar a aparência das mesmas, composições para tratar condições adversas da pele, e, para reduzir o tamanho e melhorar a aparência de cicatrizes hipertróficas
CA2488405A1 (en) Sebum and perspiration absorption foundation kit and associated multi-step method
DE50102490D1 (de) Verwendung von substituierten imidazo [1,2-a]pyridin-, -pyrimidin- und -pyrazin-3-yl-amin-derivaten zur herstellung von medikamenten zur nos-inhibierung
FR2782269B1 (fr) Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation
WO2001028491A3 (en) Method and composition for the treatment of dermatologic diseases
BR0204596A (pt) Composição tópica, e, métodos para melhorar a aparência estética da pele, para intensificar a eficácia terapêutica de uma composição tópica para a pele, unha, lábios e/ou cabelo e para intensificar a produção de um constituinte de célula de planta predeterminada
WO2001038303A3 (fr) Analogues de la vitamine d
WO2005009331A3 (fr) Utilisation d’une composition cosmetique ou pharmaceutique comprenant un extrait riche en lupeol a titre de principe actif pour stimuler la synthese des proteines de stress
NO171483C (no) Fremgangsmaate for fremstilling av et kosmetisk hudpleiepreparat mot forskjellige former for akne
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
CA2392168A1 (fr) Analogues de la vitamine d
AU2030497A (en) Propynyl or dienyl biaromatic compounds
ATE432696T1 (de) Topische zusammensetzungen mit einem natürlichen inhaltsstoff und anwendungsverfahren
WO2000050047A3 (es) Composicion para el tratamiento de la psoriasis
GB2210789A (en) Topical application for skin care
ATE227973T1 (de) Kosmetische, dermatologische und pharmazeutische anwendung eines terminalia catappa pflanzenextrakts
BR0309456A (pt) agentes de proliferação de células
BR0016959A (pt) Agente fisiologicamente ativo com ditio glicol vicinal e seu uso em diversos setores da economia
CA2505500A1 (en) Method of stimulating hair growth using benzopyrans
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
WO2004056768A3 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 00805436.3

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): BG BR CA CN HU IN JP MX RU UA US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): BG BR CA CN HU IN JP MX RU UA US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

ENP Entry into the national phase

Ref document number: 2363036

Country of ref document: CA

Ref document number: 2363036

Country of ref document: CA

Kind code of ref document: A

Ref document number: 2000 600658

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2001/00748/DE

Country of ref document: IN

Ref document number: PA/a/2001/008529

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2000 105924

Country of ref document: BG

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2000907415

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000907415

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09914257

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 2000907415

Country of ref document: EP